Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022

SELL
$0.96 - $1.78 $17,126 - $31,755
-17,840 Reduced 7.14%
231,952 $256,000
Q4 2021

Feb 10, 2022

BUY
$1.56 - $2.99 $389,675 - $746,878
249,792 New
249,792 $428,000
Q1 2021

May 11, 2021

SELL
$2.69 - $5.12 $138,400 - $263,424
-51,450 Closed
0 $0
Q4 2020

Feb 11, 2021

BUY
$2.25 - $7.12 $27,247 - $86,223
12,110 Added 30.78%
51,450 $157,000
Q3 2020

Nov 09, 2020

SELL
$3.46 - $8.39 $393,640 - $954,521
-113,769 Reduced 74.31%
39,340 $239,000
Q2 2020

Aug 12, 2020

BUY
$2.37 - $7.14 $107,434 - $323,663
45,331 Added 42.06%
153,109 $905,000
Q1 2020

May 11, 2020

BUY
$2.46 - $5.84 $17,025 - $40,418
6,921 Added 6.86%
107,778 $285,000
Q4 2019

Feb 06, 2020

BUY
$1.8 - $13.43 $181,542 - $1.35 Million
100,857 New
100,857 $274,000

Others Institutions Holding CYCN

# of Institutions
1
Shares Held
293K
Call Options Held
0
Put Options Held
0

About Cyclerion Therapeutics, Inc.


  • Ticker CYCN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,479,800
  • Market Cap $153M
  • Description
  • Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of...
More about CYCN
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.